Tumor Hypoxia and Gene Expression: Implications for Malignant Progression and Therapy

References

• Vaupel PW. Oxygenation of solid tumors. In: Teicher BA, ed. Drug resistance in oncology. New York: Marcel Dekker, Inc, 1993: 59–85.
   Google Scholar
• Stone HB, Brown JM, Phillips TL, Sutherland RM. Oxygen in human tumors: correlation between methods of measure-ment and response to therapy. Radiat Res 1993; 136: 422–34.
   PubMed Web of Science ®Google Scholar
• Raleigh J, Dewhirst M, Thrall D. Measuring tumor hypoxia. Semin Radiat Oncol 1996; 6: 37–45.
   PubMedGoogle Scholar
• Vaupel V, Schlenger K, Knoop C, Hockel M. Oxygenation of human tumors: evaluations of tissue oxygen distribution in breast cancers by computerized 02 tension measurements. Cancer Res 1991; 51: 3316–22.
   PubMed Web of Science ®Google Scholar
• Hockel M, Vomdran B, Schlenger K, et al. Tumor oxygena-tion: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 1993; 51: 141–9.
   PubMed Web of Science ®Google Scholar
• Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant pro-gression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509–15.
   PubMed Web of Science ®Google Scholar
• Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 1996; 6: 3–9.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of head and neck. Radiother Oncol 1996; 41: 31–9.
   Google Scholar
• Vaupel P. Oxygenation of human tumors: current status of knowledge. Abstract from Tumor Microenvironment Meet-ing. Martha's Vineyard, 1997.
   Google Scholar
• Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest 1968; 106 (Suppl): 145–57.
   Google Scholar
• Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int .1- Rad Oncol Biol Phys 1988; 14: 831–8.
   PubMed Web of Science ®Google Scholar
• Brizel DM, Sibley GS, Prosmitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of car-cinoma of the head and neck. Int .1- Radiat Oncol Biol Phys 1997; 38: 285–9.
   Google Scholar
• Brizel DW, Scully SP, Harrelson JM, et al. Tumor oxygena-tion predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996; 56: 941–3.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Overgaard J. Hypoxia in human tumors and clinical outcome, Abstract from Tumor Microenvironment Meeting. Martha's Vineyard, 1997.
   Google Scholar
• Bush RS, Jenkin RDT, AlIt WEC, et al. Definite evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 1978; 37: 302–6.
   Web of Science ®Google Scholar
• Schwickert G, Walenta S, Sundfor K, Rofstad EK, Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 1995; 55: 4757–9.
   Google Scholar
• Walenta S, Salameh A, Lyng et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Path 1997; 150:409–15.
   PubMed Web of Science ®Google Scholar
• Stoler DL, Anderson GR, Russo CA, Spina AM, Beerman TA, Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells. Cancer Res 1992; 52: 4372–8.
   PubMed Web of Science ®Google Scholar
• Reynolds T, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996; 56: 5754–7.
   Google Scholar
• Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR. Tumor hypoxia and heterogeneity: challenges and opportuni-ties for the future. Semin Rad Oncol 1996; 6: 59–70.
   PubMedGoogle Scholar
• Ausserer WA, Bourrat-Floeck B, Green CJ, et al. Regulation of c-jun expression during hypoxic and low-glucose stress. Mol Cell Biol 1994; 14: 5032–42.
   PubMedGoogle Scholar
• Yao K-S, Xanthoudakis S, Curran T, O'Dwyer PJ. Activa-tion of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994; 14: 5997–6003.
   Google Scholar
• Graeber TG, Peterson JF, Tsai M, et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994; 14: 6264–77.
   PubMed Web of Science ®Google Scholar
• Kastan MB, Onyekwere 0, Sidreansky D, et al. Participation of p53 in the cellular response to DNA damage. Cancer Res 1991; 51: 6304–11.
   Google Scholar
• Kastan MB, Zhan Q, El-Diery W, et al. A mammalian cell-cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587–97.
   Google Scholar
• Fornace AJ Jr, Nebert DW, Hollander MC, et al. Mam-malian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Molecular Cell Biol 1989; 9: 4196–203.
   Google Scholar
• Giaccia AJ. Hypoxic stress proteins: survival of the fittest. Semin Radiat Oncol 1996; 6: 46–58.
   PubMed Web of Science ®Google Scholar
• Lowe SW, Ruley HE, Jacks T, et al. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957–67.
   PubMed Web of Science ®Google Scholar
• Lowe SW, Jacks T, Housman DE, et al. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 1994; 91: 2026–30.
   PubMed Web of Science ®Google Scholar
• Dameron KM, Volpert OV, Tainsky MA, et al. Control of angiogenesis in fibroblasts by p53 regulation of throm-bospondin-1. Science 1994; 265: 1582–4.
   PubMed Web of Science ®Google Scholar
• Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond) 1996; 379: 88–91.
   PubMed Web of Science ®Google Scholar
• Kim CY, Tsai MH, Osmanian C, et al. Selection of human cervical epithelial cells that possess reduced apoptotic poten-tial to low-oxygen conditions. Cancer Res 1997; 57: 4200–4.
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itrin A, Soifer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-me-diated angiogenesis. Nature 1992; 349: 843–5.
   Google Scholar
• Shweiki D, Neeman M, Itin A, et al. Induction of vascular endothelial growth factor expression by hypoxia and by tu-mor angiogenesis. Proc Natl Acad Sci USA 1995; 92: 768–72.
   PubMed Web of Science ®Google Scholar
• Waleh NS, Brody MD, Knapp MA, et al. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia specific marker. Cancer Res 1995; 55: 6222–6.
   PubMed Web of Science ®Google Scholar
• Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875–87.
   PubMed Web of Science ®Google Scholar
• Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401–9.
   PubMed Web of Science ®Google Scholar
• Giaccia AJ, Alarcon RM, Brody M. The influence of hypoxia on positive and negative regulators of angiogenesis: in vitro and in vivo studies. Abstract from Tumor Microenvironment Meeting. Martha's Vineyard, 1997.
   Google Scholar
• Agani F, Kirsch DG, Friedman SL, Kastan MB, Semenza GL. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene. Cancer Res 1997; 57: 4474–7.
   Google Scholar
• Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoi-etin gene enhancer at a site required for transcriptional activa-tion. Mol Cell Biol 1992; 12: 5447–54.
   PubMed Web of Science ®Google Scholar
• Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230–7.
   PubMed Web of Science ®Google Scholar
• Wang GL, Semenza GL. Characterization of hypoxia-in-ducible factor 1 and regulation of DNA binding activity of hypoxia. J Biol Chem 1993; 268: 21513–8.
   PubMed Web of Science ®Google Scholar
• Firth JD, Ebert BL, Pugh CW, et al. Oxygen-regulated con-trol elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. Proc Natl Acad Sci USA 1994; 91: 6496–500.
   PubMed Web of Science ®Google Scholar
• Semenza GL, Roth PH, Fang HM, et al. Transcriptional regulation of genes encoding glycolytic enzymes of hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757–63.
   PubMed Web of Science ®Google Scholar
• Forsythe JA, Jiang B-H, Iyer NV, et al. Activation of vascu-lar endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604–13.
   Google Scholar
• Mazure NM, Chen KY, Yeh P, Laderoute KR, Giaccia AJ. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Can-cer Res 1996; 56: 3436–40.
   Google Scholar
• Jiang B-H, Agani F, Passaniti A, Semenza GL. V-SRC in-duces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progres-sion. Cancer Res 1997; 57: 5328–35.
   Google Scholar
• Laderoute KR, Grant TD, Murphy BJ, Sutherland RM. Enhanced epidermal growth factor receptor synthesis in hu-man squamous carcinoma cells exposed to low levels of oxygen. Int J Cancer 1992; 52: 428–32.
   PubMed Web of Science ®Google Scholar
• Heacock CS, Sutherland RM. Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br J Cancer 1990; 62: 217–25.
   PubMedGoogle Scholar
• Murphy BJ, Laderoute KR, Short SM, et al. The identifica-tion of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. Br J Cancer 1991; 64: 69–73.
   PubMed Web of Science ®Google Scholar
• O'Dwyer PJ, Yao K-S, Ford P, Godwin AK, Clayton M. Effects of hypoxia on detoxicating enzyme activity and ex-pression in HT29 colon adenocarcinoma cells. Cancer Res 1994; 54: 3082–7.
   PubMed Web of Science ®Google Scholar
• Murphy BJ, Laderoute KR, Chin RJ, et al. Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res 1994; 54: 5808–10.
   PubMed Web of Science ®Google Scholar
• Murphy BJ, Andrews GK, Bittel D et al. Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1 (In press, 1998).
   Google Scholar
• Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988; 241: 1813–5.
   PubMed Web of Science ®Google Scholar
• Goldberg MA, Dunning SP, Bunn HF. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 1988; 242: 1412–5.
   Google Scholar
• Acker H. Mechanism and meaning of cellular oxygen sensing in the organism. Respir Physiol 1994; 95: 1–10.
   PubMedGoogle Scholar
• Koong AC, Chen KY, Mivechi NF, et al. Hypoxia activation of nuclear factor-kB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res 1994; 54: 5273–9.
   PubMed Web of Science ®Google Scholar
• Koong AC, Chen EY, Kim CY, et al. Activators of protein kinase c selectively mediate cellular cytotoxicity to hypoxic cells and not aerobic cells. Int .1- Radiat Oncol Biol Phys 1994; 29: 259–65.
   PubMedGoogle Scholar
• Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activa-tion of nuclear factor kB though the phosphorylation of IkBet on tyrosine residues. Cancer Res 1994; 54: 1425–30.
   Google Scholar
• Mazure NM, Chen EY, Laderoute ER, Giaccia AJ. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 1997; 90: 3322–31.
   PubMed Web of Science ®Google Scholar
• Abate CL, Patel L, Rauscher FJ, et al. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 1990; 249: 1157–61.
   PubMed Web of Science ®Google Scholar
• Zeng J, Heuchel R, Schaffner W, et al. Thionein can modu-late DNA binding and transcription activation by zinc finger containing factor Spl. FEBS Lett 1991; 279: 310–2.
   PubMed Web of Science ®Google Scholar
• Knoepfel L, Steinkuhler C, Carri M, et al. Role of zinc-coor-dination and the glutathione redox couple in the redox sus-ceptibility of human transcription factor Spl. Biochem Biophys Res Commun 1994; 201: 871–7.
   PubMedGoogle Scholar
• Powis G, Briehl M, Oblong J. Redox signaling and the control of cell growth and death. Pharmac Ther 1995; 68: 149–73.
   Google Scholar
• Berggren M, Gallegos A, Gasdaska PY, Warneke J, Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum starva-tion and hypoxia. Anticancer Res 1996; 16: 3459–66.
   Google Scholar
• Wu X, Bishophric NH, Discher DJ, Murphy BJ, Webster KA. Physical and functional sensitivity of zinc finger tran-scription factors to redox change. Mol Cell Biol 1996; 16: 1035–46.
   Google Scholar
• Laderoute KR, Calaoagan JM, Mendonca HL. Early re-sponse of SiHa human squamous carcinoma cells to hypoxic signals: evidence of parallel activation of NF-kB and AP-1 transcriptional complexes. Intl J Oncol 1996; 8: 857–82.
   Google Scholar
• Laderoute KR, Mendonca HL, Calaoagan JM, Knapp AM, Giaccia AJ, Sutherland RM. Induction of p38 kinase and SAPK/JNK pathways in hypoxic tumor cells. Abstract from Tumor Microenvironment Meeting. Martha's Vineyard, 1997.
   Google Scholar
• Chen Y-R, Wang X, Templeton D, Davis RJ, Tan T-H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and y radiation. J Biol Chem 1996; 271: 31929–36.
   Google Scholar
• Kyriakis JM, Avruch J. Sounding the alarm-protein-kinase cascades activated by stress and inflammation. J Biol Chem 1996; 271: 24313–6.
   PubMed Web of Science ®Google Scholar
• Brown JM, Siim BG. Hypoxia-specific cytotoxins in cancer therapy. Semin Rad Oncol 1996; 6: 22–36.
   PubMed Web of Science ®Google Scholar
• Dachs GU, Patterson AV, Firth JD, et al. Targeting gene expression to hypoxic tumor cells. Nature Med 1997; 3: 515–20.
   PubMed Web of Science ®Google Scholar